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PERANAN DEHIDROEPIANDROSTERON SULFAT TERHADAP 
PEMBELAJARAN DAN DAYA INGATAN DALAM HIPOKAMPUS TIKUS 
DAN KAITANNYA DENGAN KORTEK PRAFRONTAL 
ABSTRAK 
Dehydroepiandrosterone sulfat (DHEAS) merupakan salah satu neurosteroid 
penting yang disintesis di dalam otak. Peranan DHEAS adalah penting dalam 
meningkatkan ingatan dan pembelajaran dan juga fungsi pelaksanaan. Kajian ini 
bertujuan untuk mengkaji perubahan tahap pendarflour DHEAS berdasarkan kepada 
prestasi ingatan dan pembelajaran dan prestasi pemerhatian dalam pengimejan secara 
langsung di kawasan hipokampus Cornu Ammonis 1 (CA1). Dalam kajian ini, tikus 
jantan Sprague Dawley dibahagikan kepada dua kumpulan utama bagi peranan tingkah 
laku yang berbeza iaitu Morris water maze (MWM) dan 5-Choice serial reaction time 
task (5-CSRTT). Untuk MWM, tikus yang berusia 8 minggu dan mempunyai berat 
sekitar 250-290 g manakala untuk 5-CSRTT, tikus berumur 10 minggu dengan berat 
sekitar 300-330 g dibahagikan kepada dua kumpulan yang mengandungi 9 ekor tikus 
untuk setiap kumpulan kawalan, C (kumpulan I), dan tugasan tingkah laku beserta 
pembedahan implan dan pengimejan, BP (kumpulan IIa) dan kawalan bersama 
pengimejan, CI (kumpulan IIb). Penglabelan pendarflour telah dibina sebagai penanda 
kepada DHEAS di dalam kawasan hippocampal CA1. Antibodi DHEAS 
berpendarflour dikonjugasikan bersama Alexa Fluor 5-sulfodichlorophenol (SDP) 
ester 488 dye. Pembedahan implan dan penglabelan pendarflour telah diletakkan di 
dalam kawasan hippokampal CA1 bagi MWM dan 5-CSRTT. Ujian MWM 
dilaksanakan untuk prestasi ingatan dan ruangan pembelajaran di mana 5 hari pertama 
untuk ruangan pembelajaran dan hari yang ke-6 untuk ujian probe. Ujian 5-CSRTT 
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digunakan untuk menentukan prestasi pemerhatian bagi fungsi pelaksanaan. 
Seterusnya, tikus dipengsankan dengan isofluran dan pada masa yang sama visual dan 
imej pendarflour DHEAS dalam pengimejan langsung dengan Fibre Fluorescence 
Microscopy (FFM) probe bersambungan sistem Cell Visio Lab. Tikus dibedah dan 
hipokampus dikumpulkan untuk mengesahkan kedudukan probe dengan histologi 
hematoksilin dan eosin (H&E). Konjugasi label-pendarflour yang berjaya pertama kali 
dilaporkan menunjukkan tahap penglabelan (DOL) di dalam julat yang ditetapkan dan 
signal ekspresi DHEAS pendarflour diimejkan di FFM bersambungan sistem Cell 
Visio Lab. Pengoptimuman ke atas pembedahan implan telah dilakukan untuk 
menentukan koordinat kawasan hipokampal CA1 dengan tepat. Keputusan MWM 
menunjukkan perubahan yang signifikan bagi kedua-dua kumpulan (IIa dan IIb) 
terhadap prestasi ruangan ingatan dan pembelajaran seiring dengan peningkatan 
pendarflour intensiti DHEAS. Keputusan menunjukkan bahawa pendarflour intensiti 
DHEAS meningkat disebabkan oleh peningkatan prestasi tingkah laku ruangan 
pembelajaran dan ingatan. Ujian 5-CSRTT menunjukkan tikus belajar dan terarah 
kepada tindak balas apertur yang bersesuaian. Keputusan menunjukkan prestasi 
pemerhatian dihasilkan dan integrasi dengan peningkatan pendarflour intensiti 
DHEAS. Penemuan daripada kajian ini menentukan peranan DHEAS dan hubung kait 
di antara DHEAS dengan prestasi pembelajaran dan daya ingatan dan juga fungsi 







THE ROLE OF DEHYDROEPIANDROSTERONE SULFATE ON 
LEARNING AND MEMORY IN RAT HIPPOCAMPUS AND ITS LINK TO 
THE PREFRONTAL CORTEX 
ABSTRACT 
 Dehydroepiandrosterone sulfate (DHEAS) is one of the important 
neurosteroids that are originally synthesised in the brain. The role of DHEAS is 
important in enhancing learning and memory performance, and executive functions. 
The aim of this study was to investigate the changes of DHEAS fluorescence level 
corresponding to the learning and memory task and attentional performance task in 
real time imaging in the Cornu Ammonis 1 (CA1) area of hippocampus. In this study, 
adult male Sprague Dawley rats were divided into two major different groups of 
behavioural tasks which are Morris water maze (MWM) and 5-Choice serial reaction 
time task (5-CSRTT). For MWM, eight-week-old rats weighing 250-290 g whereas 
for 5-CSRTT, ten-week-old rats weighing 300-330 g were divided into two groups of 
9 animals for control group, C (group I), and behavioural task with surgical 
implantation and imaging, BP (group IIa) and control with imaging, CI (group IIb) 
each. Fluorescence labelling was developed as a tagging to the DHEAS in the CA1 
area of hippocampus for both major groups. DHEAS antibodies were fluorescently 
conjugated with Alexa Fluor 5-SDP ester 488 dye. Surgical implantation and 
fluorescence labelling were delivered into the CA1 area of hippocampus for each task. 
The MWM test was performed for spatial learning and memory performance by which 
5 days was for the spatial learning test and on the 6th day for probe test. The 5-CSRTT 
test was used to determine attentional performance of executive function. Following 
this, the animals were anaesthetized with isoflurane and the DHEAS fluorescence was 
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simultaneously visualised and imaged in real time imaging with FFM probe connected 
to Cell Visio Lab system. The animals were dissected and their hippocampi were 
collected for the histological validation of the probe placement using hematoxylin and 
eosin (H&E) staining. The conjugation of fluorescent-labelled was the first successful 
report which demonstrated the degree of labelling (DOL) in the range of desired results 
and showed the signal of DHEAS expression on the FFM connected to the Cell Visio 
Lab system. Optimisation on surgical implantation was made to determine the 
coordinates at the CA1 area of hippocampus precisely and accurately. The results in 
MWM test indicated that both groups (group IIa and IIb) showed significant changes 
for spatial learning and memory with enhancement of DHEAS fluorescence intensity. 
The results revealed that DHEAS fluorescence intensity significantly increased due to 
spatial learning and memory performance. In the 5-CSRTT test, the results exhibited 
that the animals learned and tended to respond in an appropriate aperture. The results 
indicated attentional performance occurred and integrated with increase in the intensity 
of DHEAS fluorescence. Findings form this study were able to elucidate the role of 
DHEAS and the association between DHEAS with learning and memory 
performances as well as executive function thus linking the CA1 area of the 







1.1 Background of the study 
Dehydroepiandrosterone sulphate (DHEAS) is a neurosteroid that is found in 
greater concentration within the brain rather than in any other body organ (Dong and 
Zheng, 2011). DHEAS is synthesised from DHEA in the presence of sulfotransferase 
enzyme and can be converted back to DHEA.  Several studies have shown that DHEAS 
play a role in enhancing both learning and memory (Markowski et al., 2001; 
Bodensteiner et al., 2008) as well as executive function (Cai et al., 2018). 
Neurosteroids are endogenous steroids that are synthesised de novo in the central 
nervous system. Several neurosteroids have been identified in both human and animal 
brains, which include dehydroepiandrosterone (DHEA) and pregnenolone (PREG), 
their sulfated derivatives DHEAS and PREGS, and progesterone (PROG), 
deoxycorticosterone, 3α,5α-tetrahydroprogesterone (3α,5α-TH PROG) or 
allopregnanolone (Allo) and 3α,5α-TH DOC (Charalampopoulos et al., 2008). All 
neurosteroids are derived from the precursor cholesterol, which is transported into the 
inner mitochondrial membrane of neurosteroidogenic cells by steroidogenic acute 
regulatory protein (StAR).  
Although neurosteroids are identical to the steroid hormones that produced in 
the endocrine system, neurosteroids have a unique function and mechanism of action 
in the nervous system. In the nervous system, neurosteroids function as modulators of 
neurotransmitter receptors, such as γ-aminobutyric acid type A (GABAA) receptors, 
N-methyl-D-aspartate (NMDA) receptors, and sigma 1 receptors (Mòdol et al., 2011; 
Khare et al., 2016). Neurosteroidogenesis has been demonstrated in several types of 
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brain cells including glial cells, hippocampal pyramidal neurons and cerebellar 
Purkinje neurons (Baulieu and Robel, 1990; Mukai et al., 2006; Tsutsui et al., 2009). 
DHEAS has been demonstrated to act as an antagonist of GABAA receptors (Švob 
Štrac et al., 2012) and also a positive allosteric modulator of NMDA receptors (Svob 
Strac et al., 2016). Thus, DHEAS plays a crucial role in the enhancement of learning 
and memory via the activation of NMDA receptors (Huang et al., 2001). 
Administration of DHEAS has also been shown to enhance NMDA receptors activity 
as well as improve performance in neurocognitive-related behavioural in the 
hippocampus, where the important region of learning and memory (Chen et al., 2006). 
Thus, the hippocampus region is focused in this current study aiming to explore the 
effect of DHEAS in the modulation of learning and memory in rats. 
DHEAS has been hypotesised to modulate synaptic neurotransmission related 
to learning and memory (Dong and Zheng, 2011). There are many factors that can 
impact learning and memory, hence the observation showed that neurosteroids are one 
of the many neurobiological factors involved in learning and memory processes as 
well as impaired cognitive performance (Vallée et al., 2001). Learning and memory 
are closely related that mainly involved in the hippocampus, otherwise memory and 
executive function are fundamental processes that connected each other. Thus, this 
current study is focusing on the involvement of DHEAS in both learning and memory 
processes as well as attentional processes of executive function. Behavioural 
assessment for spatial cognition and memory can be conducted by Morris Water Maze 
(MWM) and 5-Choice Serial Reaction Time Task (5-CSRTT), the cognitive 
assessment to determine attentional performance of executive function. In this current 
study will be able to provide new insights in determining the relationship between 
neurosteroidogenesis and neurocognitive pathways.        
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Using a motorised stereotaxic apparatus guided by coordinates from a rat brain 
atlas, the FFM probe will be accurately placed in the CA1 area of the hippocampus in 
the rat brain to be imaged. Previous studies of changes in neurosteroidogenesis have 
relied on determination of DHEAS levels in brain tissue or plasma samples by using 
gas chromatography mass spectrometry or high performance liquid chromatography-
mass spectrometry (Liu et al., 2003; Lionetto et al., 2017). In addition, studies of 
neurosteroid expression in specific areas of the brain such as the hippocampus require 
cell cultures or histological approaches (Biggio, 2007). Thus, in this study there is a 
more appropriate approach to determine DHEAS fluorescence level that utilises real-
time imaging, in vivo monitoring undergoing behavioural assessment of learning and 
memory as well as executive function to stimulate specific neurocognitive pathways.     
1.2 Rationale of the study 
In recent years, there has been increasing evidence suggesting that endogenous 
neurosteroids act as paracrine modulators of neurotransmission and synaptic plasticity 
(Akk et al., 2007; Dewangan et al., 2018). Additionally, DHEAS influence 
neurocognitive functions as modulators of learning and memory processes (Wolf and 
Kirschbaum, 1999). It has been postulated that due to this role, DHEAS level increased 
in response to the modulation of learning and memory assessment, and attentional 
performance as well. However, it has yet to be established how neurosteroidogenesis 
is affected as a response to neurocognitive processes.   
Several studies have found a correlation between DHEAS levels with cognitive 
function where decreased concentrations of DHEAS levels enhanced the development 
of Alzheimer’s disease (Pan et al., 2019) as well as affect patient with Attention-
Deficit Hyperactivity Disorder (ADHD) (Strous et al., 2001; Trent et al., 2012). Thus, 
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this current study helps to provide a deeper understanding of DHEAS in order to 
explore potential therapeutic role for neurocognitive problems such as Alzheimer’s 
disease and neuropsychiatric disorders.  
In this study, changes occurring in the DHEAS fluorescence level specificly, 
in the CA1 region of the hippocampus in response to stimulation of spatial cognition, 
memory and executive function pathways of the rat brain were evaluated. To achieve 
this, novel fluorescence labelling with DHEAS monoclonal antibodies was developed 
and fluorescently labelled to endogenous DHEAS in the CA1 region of the 
hippocampus.   
Moreover, the lack of knowledge regarding neurosteroidogenesis and the 
factors affecting neurosteroid production is mostly due to analytical difficulties to 
detect and measure neurosteroidogenesis in the brain. It was found that DHEAS level 
was found in low concentrations in the brain and associated steroidogenic proteins 
(Baulieu and Robel, 1998), low sensitivity of existing techniques and unavailability of 
suitable techniques for measuring neurosteroids in the nervous system (Baulieu, 2001). 
Thus, a probe-based FFM is a recently developed technique that enables to visualise 
neural structures in specific areas of the brain (Eisenstein, 2009). This will probably 
provide new insights of knowledge and can be used as a basis for future research 






1.3 Aim of the study 
General Objective 
The main objective of this current study was to investigate the role of 
dehydroepiandrosterone sulfate (DHEAS) in the CA1 region of the rat hippocampus 
in relation to the cognitive and executive function.  
Specific Objectives 
This current study involved in vivo imaging in order  
1. To develop and optimise the fluorescence labelling method for visualisation of 
DHEAS monoclonal antibodies in real time imaging. 
2. To investigate the effects of surgical procedure on behavioural assessments. 
3. To quantify the changes occurring in the levels of dehydroepiandrosterone 
sulfate (DHEAS) in the CA1 region of the hippocampus rat brain in response 












 CHAPTER 2 
LITERATURE REVIEW 
2.1 Steroid hormones 
Steroid hormones are lipophilic molecules utilised as chemical messengers by 
organisms, in which they act on a wide range of tissues and biological functions 
(Albrecht and Pepe, 2003; Chowen et al., 2004). Active steroids are bound to transport 
proteins that increase their half-life and ensure ubiquitous distribution. The steroids 
can act by binding to cell surface receptors, binding to cytoplasmic or nucleic receptors 
and ultimately activating gene transcription (Holst et al., 2004). Steroid hormones play 
an important role in the development, growth, maturation and differentiation of the 
brain (Stoffel-Wagner, 2001).   
It is a well-established fact that steroid hormones are produced in the gonads, 
adrenal glands and the placenta which are all derived from cholesterol (Baulieu, 2001; 
Holst et al., 2004; Baulieu, 2018). The adrenal cortex within adrenal glands secrete 
mineralocorticoids, glucocorticoids, and androgens. They have three anatomic zones 
which are the zona glomerulosa, zona fasciculata and zona reticularis. Meanwhile, the 
steroid hormones produced in the gonads consist mainly of sex steroids (Holst et al., 
2004; Capper et al., 2016).  
2.1.1 Steroidogenesis 
Steroidogenesis is the biosynthesis of steroid hormones and is classified by two 
neuroendocrine axes which are the hypothalamic-pituitary adrenal axis as a pathway 
for adrenal steroidogenesis and the hypothalamic-pituitary gonadal axis for gonadal 





Figure 2.1:  Biosynthesis of steroid hormones in adrenal glands and gonads. 
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Cholesterol is the precursor for all steroid synthesis. Steroid synthesis begins 
with the translocation of cholesterol in the presence of steroidogenic acute regulatory 
(StAR) protein from the outer mitochondrial membrane to the inner mitochondrial 
membrane (Holst et al., 2004; Capper et al., 2016).  
The steroidogenesis begins with the conversion of cholesterol to pregnenolone 
(PREG) by side chain cleavage enzyme (P450scc, CYP11A1). Pregnenolone is then 
converted to progesterone in the presence of enzyme 3βHSD. Subsequently, 
CYP17A1 acts as a catalyst of PREG and progesterone to form 17OH-pregnenolone 
and 17OH-progesterone, respectively. These 17-hydroxy products are substrates for 
other enzymes in their metabolism to cortisol. Then, 17OH-pregnenolone is converted 
to dehydroepiandrosterone (DHEA) and 17OH-progesterone to androstenedione in the 
presence of enzyme CYP17A1 (17,20-lyase) (Capper et al., 2016).      
Meanwhile, gonadal steroidogenesis is primarily related to the synthesis of sex 
steroids where the ovarian theca cells are responsible for the conversion of 
androstenedione to testosterone. Testosterone is then converted to estrogen and estrone 
in the presence of aromatase (P450aro, CYP19A1) enzyme. This is followed by further 
secretion of aromatizing androgen to produce estradiol in the granulosa cells by 
17βHSD type 1. On the other hand, the testicular Leydig cells in the male gonads 
express CYP17A1 to produce androgen precursors and are converted to testosterone 
by expression of the androgenic 17βHSD3 (Capper et al., 2016). 
In the hypothalamo-pituitary adrenal (HPA) axis, neurons in the hypothalamus 
release corticotropin-releasing hormone (CRH) and stimulate adrenocorticotropin 
(ACTH) secretion in the anterior pituitary. Stimulation of cortisol and androgen 
precursors synthesis when the ACTH binds to the adrenal cortex extracellular receptor 
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on cells. Cortisol exerts negative feedback on CRH and ACTH production for 
homeostasis whereas aldosterone is primarily under the control of the renin-
angiotensin-aldosterone system (Capper et al., 2016). Meanwhile, in the hypothalamo-
pituitary gonadal (HPG) axis, the gonadotropin-releasing hormone (GnRH) is secreted 
in the neurons of the hypothalamus. The GnRH enters the portal circulation and 
stimulates luteinizing hormone (LH) and follicle-stimulating hormone (FSH) secretion 
from the gonadotropes in the anterior pituitary. In male, the LH acts on the testicular 
Leydig cells whereas FSH acts on Sertoli cells to facilitate spermatogenesis. In female, 
LH acts on the ovarian theca cells and the FSH induced the expression of the enzyme 
to convert androstenedione and testosterone from the theca cells to the estrogens and 
estradiol in granulosa cells of the ovary. Consequently, the androgens 
(androstenedione and testosterone) and estrogens exert negative feedback mechanisms 
















Figure 2.2:  Schematic diagram of proposed feedback actions and mechanisms of hypothalamo-pituitary adrenal (HPA) axis and hypothalamo-
pituitary gonadal (HPG) axis in male and female. Abbreviations: CRH, corticotropin-releasing hormone; ACTH, 
adrenocorticotropin; GnRH, gonadotrophin-releasing hormone; LH, luteinsing hormone; FSH, follicle-stimulating hormone. 





While it is an established fact that steroid hormones are produced in the gonads 
or adrenal glands and reach the brain via the blood circulation (Wingfield et al., 2018), 
nevertheless Baulieu (1981) put forward the idea that steroids can accumulate in the 
brain in the absence of steroidogenic glands and can be synthesised in the brain from 
endogenous precursors (Wingfield et al., 2018). These steroids are independently 
produced in the brain and thus are known as “neurosteroids”. The neurosteroids that 
are synthesised in the brain include dehydroepiandrosterone (DHEA) and 
pregnenolone (PREG), their sulfated derivatives DHEAS and PREGS, and 
progesterone (PROG), deoxycorticosterone, 3α,5α-tetrahydroprogesterone (3α,5α-TH 
PROG) or allopregnanolone (Allo) and 3α,5α-TH DOC (Charalampopoulos et al., 
2008; Tuem and Atey, 2017). Local endogenous neurosteroid synthesis occurs in the 
hippocampus and other brain structures where their function is to modulate synaptic 
plasticity (Mukai et al., 2006; Hojo and Kawato, 2018). Initially, observation by 
measuring the concentrations of DHEAS levels showed that greater amounts in the 
brain matter rather than in the serum (Corpéchot et al., 1981; Charalampopoulos et al., 
2008). Neurosteroids can be categorised into three components (1) pregnane 
neurosteroids, such as allopregnanolone and allotetrahydrodeoxycorticosterone 
(THDOC), (2) androstane neurosteroids, such as androstanediol and etiocholanone, 
and (3) sulfated neurosteroids, such as PREGS and DHEAS corresponding to 
structural features (Reddy, 2010).  
Within the central and the peripheral nervous system, neurosteroids are also 
produced from cholesterol, in glial cells, and in neurons. The emerging evidence 
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indicates that these neurosteroids have numerous functions within the nervous system. 
They can affect neurotransmission systems in both an excitatory or inhibitory way 
(Maurice et al., 1999; Mellon, 2007; Dewangan et al., 2018). They can also act as 
modulators of neurotransmitter receptors, such as GABAA receptors, NMDA 
receptors, and sigma 1 receptors (Mòdol et al., 2011; Khare et al., 2016). The GABAA 
receptor is a member of the ligand-gated ion channel family which is modulated by 
several effector sites which bind benzodiazepines, barbiturates and ethanol. On the 
other hand, NMDA receptors are involved in long-term potentiation (LTP), memory 
and learning, hypoxic/ischemic neuronal damage and epilepsy (Kawato et al., 2003) 
while other neurosteroids activate important glial functions, such as myelination 
(Baulieu and Schumacher, 2000). Thus, it can be seen that these neurosteroids have a 
neuromodulatory function with the potential to be used as therapeutic agents for 
various conditions such as neuropsychiatric disorders, Alzheimer’s disease, anxiety 
disorders, stress sensitive conditions and epilepsy (Herbert, 2001). Thus, this current 
study helps to provide a deeper understanding of neurosteroidal function as a step 
towards exploring various opportunities for therapeutic development (Reddy, 2010).  
While neurosteroids have many functions in the brain, their concentrations can 
vary according to environmental and behavioural circumstances, such as stress, sex 
recognition, aggressiveness, depression, anxiety, sleep, epilepsy, and memory 
formation (Maurice et al., 1999; Tuem and Atey, 2017). Neurosteroids have also been 
proposed as one of the neurobiological factors involved in the disruption of cognitive 
processes in aging (Beason-held et al., 2005; Powrie and Smith, 2018). Research 
shows that the alteration of neurosteroids with age is linked to disruption of both 
learning and memory processes. This has led to the hypothesis that varying 
concentrations of steroids may affect both physical and cognitive aging (Vallée et al., 
13 
 
2001). To this end, animal studies are necessary in order to examine various 
neurosteroids levels under physiological, pathological and clinical conditions.  Thus, 
in this current study, animal studies were conducted to determine the location of the 
neurosteroid dehydroepiandrosterone sulfate and to develop a method for the analysis 
of neurosteroid levels in the brain.   
It is not only the concentration of neurosteroids that affect the brain. The 
different metabolites have either inhibitory or excitatory effects in the brain.  
Allopregnanolone is one of the metabolites of progesterone (PROG) which has shown 
an ability to inhibit neural activity through the modulation of GABAA receptors 
(Majewska et al., 1986; Wang, 2011). It has also been shown that allopregnanolone 
can inhibit learning in animals undergoing a Morris water maze test (Johansson et al., 
2002). On the other hand, numerous studies have shown that pregnenolone sulfate 
(PREGS) is one of the neurosteroids that is a negative modulator of GABAA receptor 
as well as a positive modulator of NMDA (Smith et al., 2014). Administration of 
PREGS to rats undergoing the Morris water maze and Y-maze tasks showed that their 
performance in learning and spatial memory was enhanced (Vallée et al., 1997; 
Darnaudéry et al., 2000).  
To add further to the complexity of the effect of neurosteroids in the brain, it 
has been shown that the sex steroids can cross the blood brain barrier and influence 
neuronal functions in the brain (Baulieu and Schumacher, 2000). Previous reported 
studies showed that receptors of androgens increase the number of synaptic contacts 
in a group of spinal motor neurons (Matsumoto et al., 1988; Verhovshek and 
Sengelaub, 2013), oestrogens increase the density of dendritic spines of hypothalamic 
and hippocampal neurons (Frankfurt and Luine, 2015), and progesterone prevent death 
of facial motor neurons after nerve transection (Yu, 1989). Indeed, Adhya and co-
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researchers (2017) have also shown that sex steroids are able to act as therapeutic 
agents in neuronal injury.  
The modulation of neuronal activity involves the synaptic release of 
neurochemicals where it regulates the amplitude or frequency of postsynaptic 
membrane potentials (Schlinger and Remage-Healey, 2011). This can be seen in terms 
of synaptic plasticity, where estradiol synthesis can modulate spine density, long-term 
potentiation (LTP), long-term depression (LTD), and learning and memory in the 














Figure 2.3: Schematic illustration of the neurosteroids modulation of synaptic 
plasticity. 1) Glutamate release from the presynapse and binds to 
NMDA receptors and induces Ca2+ influx; 2) The Ca2+ influx drives 
StAR as a cholesterol transportation into the mitochondria, where the 
conversion from cholesterol to pregnenolone by P450scc; 3) The 
conversion from PREG to DHEA to androstenediol to testosterone to 
estradiol or testosterone to dihydrotestosterone in the presence of 
P45017α, 3β-HSD, P450arom, 17β-HSD which are located in the 
synaptic membrane; and 4) Estradiol binds to synaptic ERα and 
activation of MAP kinase phosphatase pathway induced the 
modulation of long-term depression (LTD) and new spine appeared. 















2.2.1 Neuroactive neurosteroids  
Dehydroepiandrosterone (DHEA), unconjugated steroid and its sulphate ester 
(DHEAS) are the most abundant circulating hormones in humans (Baulieu and Robel, 
1998; Maninger et al., 2009; Rutkowski et al., 2014) and has been shown to have 
multiple effects in animals  (Baulieu and Robel, 1998; Maninger et al., 2009; Sujkovic 
et al., 2011; Chen et al., 2014). Dehydroepiandrosterone and DHEAS are steroids 
which can exist as circulating hormones or produced within the brain from cholesterol. 
In particular, several studies reported that the existence of DHEA and DHEAS at low 
amounts in the rat’s brain (Liere et al., 2009). Dehydroepiandrosterone and DHEAS 
were the first neurosteroids to be identified in large concentrations in the rat’s brain 
(Corpéchot et al., 1981; Charalampopoulos et al., 2008). An examination of whole rat 
brains have found 6.47 ng/g DHEAS and 0.54 ng/g DHEA, which are greater than that 
found in the plasma (Corpéchot et al., 1981). It has been shown that both the DHEA 
and DHEAS are synthesised in the brain from cholesterol (Baulieu and Robel, 1998; 
Dong and Zheng, 2011; Stárka et al., 2015).   
Dehydroepiandrosterone and DHEAS may influence the cognitive function. 
Flood and co-researchers (1988) were the first to report that DHEA and DHEAS 
improved learning and memory in a variety of learning and memory tasks in animals. 
For example, the effects of DHEA and DHEAS enhanced neural and glial cell survival 
and/or differentiation of dissociated cell cultures in 14-day-old mice (Roberts et al., 
1987). Some studies have demonstrated DHEA and DHEAS enhanced the 
performance in various cognitive tasks such as Morris water maze, Y-maze and 
passive avoidance tasks (Frye and Lacey, 1999). Indeed, the evidence that DHEA and 
DHEAS is associated with learning and memory enhancement is further strengthened 
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by other supporting studies.  DHEA and DHEAS have been shown to alter cognitive 
performance in rats (Frye and Lacey, 1999) while several other studies have 
demonstrated that these compounds improved memory retention in passive and active 
footshock avoidance (Reddy and Kulkarni, 1998) and T-maze tasks (Melchior and 
Ritzmann, 1996) in male mice. Thus, the evidence seems to indicate that both DHEA 
and DHEAS have with similar complementary effects on memory enhancement but 
on different behavioural tasks. Administration of DHEA (3.0 mg/kg) and DHEAS 
showed that DHEA can affect the cognitive performance on water maze task while 
DHEAS did not showed any effect on water maze task. On the other hand, DHEA did 
not show any significant differences on Y-maze task but DHEAS enhanced the 
cognitive performance on Y-maze task in a dose-dependent manner (0 mg/kg, 3.0 
mg/kg and 7.5 mg/kg) (Frye and Lacey, 1999). These complementary effects of both 
DHEA and DHEAS on memory enhancement and cognitive performance in rats 
suggest that there is a link to their neurotransmitter receptors (Wolf and Kirschbaum, 
1999). Moazedi et al. (2008) has investigated this idea and found that the NMDA 
receptor is indeed involved in the mechanisms related to learning and memory 
impairment.  
Moreover, there is evidence that neurosteroids regulate neuronal function by 
binding to intracellular receptors with a concurrent influence on neuronal excitability 
and gene expression (Rupprecht and Holsboer, 1999; Rupprecht et al., 2001; 
Rupprecht, 2003; Balthazart et al., 2018). Thus, the genomic (classical intracellular 
steroid receptors) and non-genomic (ion channels and membrane receptors) effects of 
steroids in the brain may contribute to the mechanism of steroids action on neuronal 
function and plasticity (Rupprecht, 2003; Tuem and Atey, 2017; Balthazart et al., 





Figure 2.4:  Schematic illustrations of non-genomic and genomic effects of 
neuroactive steroids (DHEAS). Abbreviations: BDZ, 
benzodiazepines; R, receptor; G, G-protein; PKA, protein kinase A; 
HSP 90, heat shock protein 90; GR, glucocorticoid receptor; MR, 
mineralocorticoid receptor; PR, progesterone receptor; ER, estrogen 











Steroid hormones act via the classical genomic pathway, whereas neuroactive 
steroids do not bind to steroid receptors.  However, they act as modulators of ligand-
gated ion channels. Steroid hormone actions via intracellular steroid receptors are 
usually slow and prolonged duration, whereas the physiolgical effects of neuroactive 
steroids occur within hours or minutes. On the other hand, steroid hormones may 
influence neuronal excitability by interfering with the expression patterns of 
neurotransmitter-receptors and voltage-gated ion channels, and through modulation of 
ligand-gated ion channels or G-protein-coupled receptors by alteration of the 
intracellular kinases activity. Furthermore, steroids in the brain are highly complex and 
do not exhibit high-affinity interaction with nuclear steroid hormone receptors 
(Rupprecht et al., 1996; Rebas et al., 2017).  
Neuroactive steroids have been demonstrated to act as a direct modulator to 
ligand-gated ion channels and most notably steroid-binding site exists at the GABAA 
receptors (Lambert et al.,  2003; Wang, 2011). The effects of progesterone at GABAA 
receptors might exert sedative, anesthetic, anxiolytic, sleep modulating and 
anticonvulsant activity in animals and humans (Rupprecht and Holsboer, 1999; 
Lambert et al., 2003; Rupprecht, 2003; Belelli et al., 2009), whereas classical steroid 
receptor is not required for that activity of progesterone and related neurosteroids 
(Reddy et al., 2005). Animal studies have shown  that negative allosteric modulators 
of GABAA receptors and positive NMDA receptors may produce neuroprotective 
properties and memory enhancement (Wolf and Kirschbaum, 1999). These actions of 
neuroactive steroids provide various opportunities and potential for the development 






Neurosteroidogenesis is defined as the biosynthesis of endogenous steroids in 
the brain (Dong and Zheng, 2011). Neurosteroidogenesis has an important role in the 
modulation of neurophysiological and neuropsychological function. It is also involved 
in the regulation of synaptic plasticity and contributes to the effects of 
neurotransmission, dendritic spine formation, long-term potentiation or depression, as 
well as learning and memory (Frankfurt and Luine, 2015; Porcu et al., 2016; Bazzari 
and Parri, 2019).  
The presence of the steroidogenic acute regulatory protein (StAR) plays an 
essential role in neurosteroidogenesis as cholesterol is transported into the 
mitochondria in the presence of steroidogenic acute regulating protein (StAR) (Sierra, 
2004; Porcu et al., 2016).  
Meanwhile, in the mitochondria, neurosteroidogenesis begins with the 
conversion of pregnenolone (PREG) from cholesterol in the presence of cytochrome 
P450scc (CYP11A1) (Sierra, 2004; MacKenzie and Maguire, 2013).  Pregnenolone is 
then converted to progesterone in the presence of Δ5-3β-hyroxysteroid dehydrogenase 
isomerase (3β-HSD). The progesterone is then converted to 5α-dihydroprogesterone 
by 5α-reductase and subsequently to 3α,5α-tetrahydroprogesterone (allopregnanolone) 
by 3α-hydroxysteroid oxidoreductase (Maurice et al., 1999; Kawato et al., 2003; 
Charalampopoulos et al., 2008; Maninger et al., 2009; Dong and Zheng, 2011;) 








Figure 2.5:  Biosynthesis pathways of neurosteroids in the hippocampus. Adapted 











Pregnenolone is also a precursor for dehydroepiandrosterone (DHEA). 
Dehydroepiandrosterone is a 19-carbon steroid hormone classified as an adrenal 
androgen. It is derived from the conversion of pregnenolone to DHEA by cytochrome 
P450c17 (Charalampopoulos et al., 2008; Maninger et al., 2009; Dong and Zheng, 
2011; Diotel et al., 2018). In addition, P450c17 is also expressed in the rat 
hippocampus (Compagnone et al., 1995; Kawato et al., 2003; Hojo et al., 2004). 
Finally, the conversion of DHEA into its sulphated derivative DHEAS is catalysed by 
hydroxysteroid sulfotransferase. DHEAS is also known to be metabolically 
interconvertible to DHEA through hydrolysis by a sulphatase (Maninger et al., 2009; 
Dong and Zheng, 2011).  
Interestingly, cytochrome P450scc, hyroxysteroid sulfotransferase, 
cytochrome P45017α (CYP17), cytochrome P450arom, steroidogenic acute regulatory 
protein (StAR) and 3β-hydroxysteroid dehydrogenase/ Δ5-Δ4-isomerase (3β-HSD) 
have all been found to be expressed in the hippocampus and Purkinje cells of adult 
male rats as seen in various studies involving immunohistochemical staining and 
confocal laser scanning microscopy, RT-PCR analysis, and enzyme activity assays 
(Kimoto et al., 2001; Matsunaga et al., 2001; Hojo et al., 2004). Immunohistochemical 
evidence has also shown presence of P450scc, P45017α, and P450arom within the 
hippocampus (Kawato et al., 2003). Indeed, Dewangan et al., 2018 also reported that 
the acute modulation of neurotransmission can occur within the hippocampus with 
both excitatory and / or inhibitory effects.   
Recently, several studies have also shown that hydroxysteroid sulfotransferase 
activity was present in the rat brain (Aldred and Waring, 1999; Qaiser et al., 2017). It 
has also been shown that sulfatase activity which has a role in neurosteroidogenesis, 
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is widely present in the central nervous system and affects memory inhibition (Rhodes 
et al., 1997; Kříž et al., 2008).   
2.2.3 Dehydroepiandrosterone sulfate (DHEAS) 
Dehydroepiandrosterone sulfate (DHEAS) is one of the vital neurosteroids 
which is derived from dehydroepiandrosterone (DHEA) in the presence of 
sulphotransferase enzymes (Dong and Zheng, 2011). DHEAS is reversibly synthesised 
from and hydrolysed to the corresponding free steroid DHEA (also secreted by the 
adrenals), which itself can be partially metabolised into active androgens and estrogens 
in peripheral tissues (Berr et al., 1996; Stárka et al., 2015). The enzyme hydroxysteroid 
sulfotransferase is a catalyst which transforms DHEA into the more stable sulfate ester 
DHEAS which can then be converted back to DHEA by sulfatase enzymes (Maninger 
et al., 2009) (Figure 2.6).  
Several studies have shown that the presence of DHEAS increased the neuronal 
excitability, enhanced neuronal plasticity, possessed neuroprotective properties, anti-
glucocorticoid effects and improved memory and learning (Wolf and Kirschbaum, 
1999; Maninger et al., 2009; Hӧllig et al., 2015). DHEAS has a longer biological half-
life (7 – 10 h) compared to DHEA which has a short half-life (30 min or less) (Wolf 
and Kirschbaum, 1999). Several studies demonstrated that there are relatively high 
levels of DHEAS in both animals and humans (Corpéchot et al., 1981; Lanthier and 
Patwardhan, 1986; Lennartsson et al., 2012; Lionetto et al., 2017), with higher 
concentrations of DHEAS in man (Goldman and Glei, 2007) and comparatively very 
low concentrations in rats and mice (Fleshner et al., 1997; Liere et al., 2009) which 
may be related to very low expression of P450c17α enzyme (Baulieu and Robel, 1998; 
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Dong and Zheng, 2011; Diotel et al., 2018). This is supported by a study in adult male 
rats which reported that DHEAS levels in the anterior and posterior areas of  the brain 
was in the range of  1.58 ± 0.14 and 4.89 ± 1.06 ng/g, respectively (Corpéchot et al., 
1981).  
 
 
 
 
 
 
 
